Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 1.640B
December 31, 2025 1.355B
June 30, 2025 1.165B
December 31, 2024 975.49M
June 30, 2024 843.45M
December 31, 2023 755.11M
June 30, 2023 643.14M
December 31, 2022 560.67M
June 30, 2022 579.83M
December 31, 2021 575.45M
June 30, 2021 470.53M
Date Value
December 31, 2020 386.87M
June 30, 2020 319.00M
December 31, 2019 218.45M
June 30, 2019 143.80M
December 31, 2018 97.71M
June 30, 2018 71.78M
December 31, 2017 58.25M
June 30, 2017 49.83M
December 31, 2016 34.42M
June 30, 2016 24.77M
December 31, 2015 22.60M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Autolus Therapeutics Plc 115.59M
Cellectis SA 120.18M
Halozyme Therapeutics, Inc. 112.90M
Biodexa Pharmaceuticals Plc 6.997M
DBV Technologies SA 137.27M